BCL2 and acute myeloid leukemia: Together, these data indicated that high-UNC93B1 expressed AML cells shows greater dependence on MCL1 than BCL2 for survival, and UNC93B1 might be a biomarker to predicting drug response in acute myeloid leukemia.